CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 25 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,378,685 | -39.4% | 2,027,000 | -19.8% | 0.07% | -36.5% |
| Q2 2023 | $3,922,409 | -3.7% | 2,527,000 | -22.6% | 0.10% | -5.5% |
| Q1 2023 | $4,072,166 | +8.3% | 3,264,000 | 0.0% | 0.11% | +8.9% |
| Q4 2022 | $3,759,802 | -2.7% | 3,264,000 | -8.4% | 0.10% | -8.2% |
| Q3 2022 | $3,865,000 | -10.4% | 3,564,000 | 0.0% | 0.11% | -6.0% |
| Q2 2022 | $4,312,000 | -29.7% | 3,564,000 | 0.0% | 0.12% | -17.0% |
| Q1 2022 | $6,134,000 | +2.2% | 3,564,000 | -1.3% | 0.14% | +15.6% |
| Q4 2021 | $6,004,000 | -22.6% | 3,611,000 | -27.8% | 0.12% | -27.8% |
| Q3 2021 | $7,762,000 | -7.8% | 4,998,000 | -4.0% | 0.17% | -11.1% |
| Q2 2021 | $8,417,000 | -14.2% | 5,208,000 | -17.0% | 0.19% | -17.7% |
| Q1 2021 | $9,814,000 | +32.9% | 6,271,000 | +19.0% | 0.23% | +22.2% |
| Q4 2020 | $7,387,000 | +25.1% | 5,271,000 | 0.0% | 0.19% | +8.0% |
| Q3 2020 | $5,903,000 | +39.4% | 5,271,000 | +31.4% | 0.18% | +29.6% |
| Q2 2020 | $4,234,000 | +24.3% | 4,010,000 | +9.9% | 0.14% | +12.5% |
| Q1 2020 | $3,407,000 | – | 3,650,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $4,888,000 | 0.98% |
| III Capital Management | 3,669,000 | $4,453,000 | 0.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,972,000 | $4,789,000 | 0.29% |
| MACKAY SHIELDS LLC | 6,783,000 | $8,195,000 | 0.20% |
| Warberg Asset Management LLC | 722,000 | $875,000 | 0.19% |
| ZAZOVE ASSOCIATES LLC | 1,628,000 | $1,967,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,564,000 | $4,312,000 | 0.12% |
| Teton Advisors, Inc. | 350,000 | $423,000 | 0.09% |
| Calamos Wealth Management LLC | 823,000 | $998,000 | 0.09% |
| WESTWOOD HOLDINGS GROUP INC | 4,310,000 | $5,263,000 | 0.06% |